InvestSMART

Universal Biosensors, Inc. (ASX: UBI) - Announcements

DELISTED - Current share price for UBI : $0.014

ASX company news and announcements for Universal Biosensors, Inc. (UBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Biosensors, Inc. (UBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Biosensors, Inc. (UBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Biosensors, Inc. (UBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 2025 Notice of Meeting / Proxy Statement 15 Apr 2025 10:36AM $0.062 $0.014 fallen by 77.42%
$4 Preliminary Proxy Statement/Notice of Meeting 4 Apr 2025 11:06AM $0.066 $0.014 fallen by 78.79%
$4 Appendix 3Z - John Sharman 2 Apr 2025 4:19PM $0.068 $0.014 fallen by 79.41%
$4 Managing Director & Chief Executive Officer Appointment 1 Apr 2025 8:29AM $0.069 $0.014 fallen by 79.71%
$4 Notification of cessation of securities - UBI 25 Mar 2025 10:04AM $0.073 $0.014 fallen by 80.82%
$4 Chairman's Letter 17 Mar 2025 8:37AM $0.072 $0.014 fallen by 80.56%
$4 FY2024 Annual Results Presentation 26 Feb 2025 3:21PM $0.074 $0.014 fallen by 81.08%
$4 FY2024 Appendix 4G and Corporate Governance Statement 26 Feb 2025 3:16PM $0.074 $0.014 fallen by 81.08%
$4 Appendix 4E and Annual Report FY2024 26 Feb 2025 3:15PM $0.074 $0.014 fallen by 81.08%
$4 Change of Company Secretary 12 Feb 2025 3:37PM $0.084 $0.014 fallen by 83.33%
$4 Investor Presentation - The Microcap Conference USA 29 Jan 2025 8:54AM $0.083 $0.014 fallen by 83.13%
$4 December 2024 Quarterly Activity Report and Appendix 4C 24 Jan 2025 1:46PM $0.085 $0.014 fallen by 83.53%
$4 Petrackr deals with Chewy and Amazon 23 Jan 2025 10:55AM $0.093 $0.014 fallen by 84.95%
$4 Initial Director's Interest Notice - Peter Mullin 17 Jan 2025 11:29AM $0.095 $0.014 fallen by 85.26%
$4 Initial Director's Interest Notice - John Sharman 17 Jan 2025 11:27AM $0.095 $0.014 fallen by 85.26%
$4 UBI Board Additions 15 Jan 2025 9:03AM $0.096 $0.014 fallen by 85.42%
$4 Notification of cessation of securities - UBI 10 Jan 2025 11:10AM $0.100 $0.014 fallen by 86%
$4 Appointment of Peter Mullin as Finance Director & CFO 31 Dec 2024 9:47AM $0.100 $0.014 fallen by 86%
$4 UBI signs NDC as its distribution partner for Xprecia Prime 19 Nov 2024 9:44AM $0.120 $0.014 fallen by 88.33%
$4 UBI signs Henry Schein as distribution partner for Xprecia 8 Nov 2024 10:19AM $0.125 $0.014 fallen by 88.80%
$4 Q3 2024 Results Presentation 31 Oct 2024 12:04PM $0.125 $0.014 fallen by 88.80%
$4 Q3 2024 Results 31 Oct 2024 12:03PM $0.125 $0.014 fallen by 88.80%
$4 September 2024 Quarterly Activity Report and Appendix 4C 31 Oct 2024 11:57AM $0.125 $0.014 fallen by 88.80%
$4 Notification regarding unquoted securities - UBI 8 Oct 2024 4:09PM $0.145 $0.014 fallen by 90.34%
$4 Xprecia Prime deal in India (Revised) 26 Aug 2024 11:08AM $0.150 $0.014 fallen by 90.67%

26 - 50 of 640 results

Page 2 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.